롱
DopeCoin (DOPE) 2nd Entry (200%+ Profits Potential)

DopeCoin (DOPE) 2nd Entry by Alan Masters
DopeCoin (DOPE) charts signals are showing room for a second entry. Let's give it a try for an additional trade for this coin.
Looking at the daily chart, we have a very strong buy signal, coming from the 4+ month old bullish divergence on the MACD.
TRADE INSTRUCTIONS
Buy in: Up to 0.00000410
DopeCoin Targets:
SHORT TERM
(1) 517
(2) 619
(3) 783
(4) 900
Stop loss: 0.00000300
Capital allocation: Up to 2%.
Time: 2-4 weeks.
Thank you!
Namaste.
DopeCoin (DOPE) charts signals are showing room for a second entry. Let's give it a try for an additional trade for this coin.
Looking at the daily chart, we have a very strong buy signal, coming from the 4+ month old bullish divergence on the MACD.
TRADE INSTRUCTIONS
Buy in: Up to 0.00000410
DopeCoin Targets:
SHORT TERM
(1) 517
(2) 619
(3) 783
(4) 900
Stop loss: 0.00000300
Capital allocation: Up to 2%.
Time: 2-4 weeks.
Thank you!
Namaste.
노트
Strong bullish divergence on the MACD.DopeCoin (DOPE) will have its time soon...
🚨 LIFETIME (Pay 1, Get 7)
lamatrades.com —Since 2017
🚨 Results
ETH +2150%
CRO +1272%
AAVE +1134%
DOGS +868%
SOL +861%
XRP +749%
BTC +580%
t.me/masteranandatrades/6681
😱 Wow & New Results
t.me/anandatrades/1350
lamatrades.com —Since 2017
🚨 Results
ETH +2150%
CRO +1272%
AAVE +1134%
DOGS +868%
SOL +861%
XRP +749%
BTC +580%
t.me/masteranandatrades/6681
😱 Wow & New Results
t.me/anandatrades/1350
관련 발행물
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.
🚨 LIFETIME (Pay 1, Get 7)
lamatrades.com —Since 2017
🚨 Results
ETH +2150%
CRO +1272%
AAVE +1134%
DOGS +868%
SOL +861%
XRP +749%
BTC +580%
t.me/masteranandatrades/6681
😱 Wow & New Results
t.me/anandatrades/1350
lamatrades.com —Since 2017
🚨 Results
ETH +2150%
CRO +1272%
AAVE +1134%
DOGS +868%
SOL +861%
XRP +749%
BTC +580%
t.me/masteranandatrades/6681
😱 Wow & New Results
t.me/anandatrades/1350
관련 발행물
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.